77 related articles for article (PubMed ID: 8143564)
1. [The coagulation parameters in high-dosage intravenous heparin therapy].
Weidmann B
Dtsch Med Wochenschr; 1994 Mar; 119(12):442. PubMed ID: 8143564
[No Abstract] [Full Text] [Related]
2. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
Ray PK; Harper TA
J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
[No Abstract] [Full Text] [Related]
3. Heparin therapy by continuous intravenous infusion.
Swanson M; Cacace L
Am J Hosp Pharm; 1971 Oct; 28(10):792-5. PubMed ID: 5125174
[No Abstract] [Full Text] [Related]
4. [Coagulation parameters in high-dosage intravenous heparin therapy].
Hafner G
Dtsch Med Wochenschr; 1993 Aug; 118(31):1131-2. PubMed ID: 8344170
[No Abstract] [Full Text] [Related]
5. [Concerning the article "Problem of heparin dosage" by G. Mombelli].
Krahenbuhl B
Schweiz Med Wochenschr; 1984 Aug; 114(31-32):1102-3. PubMed ID: 6494861
[No Abstract] [Full Text] [Related]
6. Kinetic model for intravenous heparin infusion.
Bauwens S; Dukes GE
Am J Hosp Pharm; 1980 Jan; 37(1):26, 31, 37 passim. PubMed ID: 7361772
[No Abstract] [Full Text] [Related]
7. [Monitoring heparin therapy].
Wettendorff P
Rev Med Brux; 1983 Jan; 4(1):27-31. PubMed ID: 6836204
[No Abstract] [Full Text] [Related]
8. Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
Fitzgerald D
Perfusion; 2009 Mar; 24(2):97. PubMed ID: 19654151
[No Abstract] [Full Text] [Related]
9. [The effect of subcutaneous depot heparin on certain coagulation parameters (preliminary report)].
Petö I; Blaskó G; Sas G
Orv Hetil; 1981 Jan; 122(3):145-6. PubMed ID: 7220045
[No Abstract] [Full Text] [Related]
10. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
Ohyama T; Hori T; Moriike M; Asano T; Hayashi H; Iwade K; Hosoda S
Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
[TBL] [Abstract][Full Text] [Related]
11. [Monitored heparin therapy of sepsis].
Bochorishvili VG; Makhviladze NM; Gigauri MK; Tkeshelashvili MG; Bokhua AA
Voen Med Zh; 1987 Sep; (9):33-5. PubMed ID: 3686848
[No Abstract] [Full Text] [Related]
12. [Effect of heparin on proteinuria and other biochemical parameters in nephrotic syndrome].
Poplawski A
Pol Tyg Lek; 1974 Mar; 29(10):289-91. PubMed ID: 4826144
[No Abstract] [Full Text] [Related]
13. [Use of intramuscular administration of heparin in anticoagulant therapy].
BROUSTET ; POUQUET ; BRICAUD
J Med Bord; 1954 Apr; 131(4):371-5. PubMed ID: 13184258
[No Abstract] [Full Text] [Related]
14. Low heparinization and heparin-bonded circuits.
Hill RC
Ann Thorac Surg; 1997 Oct; 64(4):1221-2. PubMed ID: 9354574
[No Abstract] [Full Text] [Related]
15. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
16. Activated clotting time (ACT)-guided intravenous dalteparin dosing during percutaneous coronary intervention.
Marmur JD; Poludasu S; Feit A; Battala VR; Cavusoglu E
J Invasive Cardiol; 2008 Jul; 20(7):323-7. PubMed ID: 18599887
[TBL] [Abstract][Full Text] [Related]
17. [Anticoagulant treatment with heparin].
Langer B; Wolosker M; Albers MT
Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
[No Abstract] [Full Text] [Related]
18. Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers.
Frank RD; Altenwerth B; Brandenburg VM; Nolden-Koch M; Block F
Thromb Haemost; 2005 Aug; 94(2):467-8. PubMed ID: 16116692
[No Abstract] [Full Text] [Related]
19. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
20. Low-dose heparin therapy.
Chamberlain SL
Am J Nurs; 1980 Jun; 80(6):1115-7. PubMed ID: 6446861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
